ArticleJournal of blood medicine2019

Real-world experience of ibrutinib therapy in relapsed chronic lymphocytic leukemia: results of a single-center retrospective analysis.

Elisabeth Nuttall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.